Table 3.

Comparison of evaluation moments and groups in relation to body composition, lung function, 6MWT, and BODE index.

N = 26	Control group (N = 13)		Intervention group (N = 13)		p time	p group	p TxG
	Hospitalization	After one month	Hospitalization	After one month
BMI	23.3 ± 4.4	24.2 ± 6.1	25.4 ± 4.8	26.5 ± 5.09	0.89	0.18	0.33
LBMI	16.0 ± 3.6	15.6 ± 6.8	15.7 ± 2.1	17.5 ± 2.1	0.36	0.45	0.38
FEV1 (%)	39.0 ± 9.6	40.4 ± 15.0	32.6 ± 15.2	40.9 ± 14.1	0.05	0.51	0.45
FEV1 (L)	0.89 ± 0.29	1.02 ± 0.41	0.74 ± 0.32	0.91 ± 0.28	0.12	0.75	0.4
FVC (%)	60.1 ± 12.2	68.7 ± 18.2	55.7 ± 18.8	63.5 ± 18.5	0.09	0.89	0.55
FVC (L)	1.82 ± 0.64	2.05 ± 0.78	1.63 ± 0.57	1.82 ± 0.51	0.23	0.87	0.49
FEV1/FVC (L)	0.45 ± 0.09	0.50 ± 0.09	0.45 ± 0.09	0.50 ± 0.10	0.05	0.95	0.95
BODE	5.6 ± 1.9	5.0 ± 2.3	6.3 ± 1.7	4.4 ± 2.0	0.002	0.85	0.24
6MWT	219.0 ± 38.4	269.5 ± 28.1	190.7 ± 40.3	277.4 ± 29.5	0.02	0.97	0.26

Values are expressed as mean ± standard deviation. LBMI, lean body mass index; BMI, body mass index; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; 6MWT, six-minute walk test; BODE, body mass index, airway obstruction, dyspnea, and exercise capacity; p < 0.05, comparison evaluated by the two-way ANOVA test with repeated measures.